All In Biotech

Drug Trial Radar · NCT05095844

National Vaccine Adverse Event Reporting Survey and Etiology

National Vaccine Adverse Event Reporting Survey to Determine the Etiology of Vaccine-Induced Injury

Last checked: Nov 19, 2026Latest source record: Mar 18, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

100,000

Planned (sponsor's estimate)

Start

Mar 15, 2022

Primary completion

Apr 1, 2024

Study completion Apr 1, 2024

Sponsor

Lead sponsor
Neuroganics LLCIndustry
Sponsor type
Industry
Collaborators
Ramos Injury Law Firm
First posted
Oct 27, 2021

More drug trials from this sponsor

Design

Study type
Observational
FDA-regulated drug
Yes
Who can join
All sexes, from 5 years, up to 99 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

If your serious vaccine-induced adverse event has been entered in the CDC Vaccine Adverse Event Reporting System (VAERS) we are interested in enrolling you for this study in order to log your symptoms. The primary goal of this study is to create a national database and gather vaccine-associated serious adverse events/injury data from newly vaccinated individuals in the US in order to identify the possible underlying causal relationships and plausible underlying biological mechanisms. The project aims to identify the genetic determinants of vaccine-induced adverse response by studying host genetics. We plan to use whole genome sequencing to identify single nucleotide polymorphisms associated with cardiovascular, neurological, gastrointestinal, musculoskeletal and immunological symptoms induced by vaccine administration. The secondary goal is to establish criteria that enable classification of vaccine-induced adverse events/injuries compare data from our database with the official Vaccine Injury Table National Vaccine Injury Compensation Program on or after March 21, 2017. The tertiary goal is to establish a database to gather detailed long-term adverse reaction data from subjects enrolled in FDA Emergency Use Authorized vaccine clinical trials.

Conditions

  • COVID-19
  • Vaccine Adverse Reaction
  • Vaccine Reaction
  • Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use
  • Corona Virus Infection
  • Blood Clot
  • Thrombocytopenia
  • Neuritis
  • Vasculitis
  • Influenza
  • Guillain-Barré
  • GWAS
  • Genetic Sequencing

Interventions

  • vaccinatedBiological

    Pfizer-BioNTech COVID-19 Vaccine, Moderna or J\&J/Janssen COVID-19 Vaccine, Diphtheria (e.g., DTP, DTaP, Tdap, DT, Td, TT) Haemophilus influenza type b polysaccharide conjugate vaccines (e.g., Hib) Hepatitis A (e.g., HAV) Hepatitis B (e.g., HBV) Human papillomavirus (e.g., HPV) Seasonal influenza (e.g., Flu) Measles (e.g., MMR) Mumps (e.g., MMR, MR, M) Meningococcal (e.g., MCV4, MPSV4, MenB-FHbp, MenB-4C) Pertussis (e.g., DTP, DTaP, Tdap) Pneumococcal conjugate (e.g., PCV) Polio (e.g., OPV or IPV) Rotavirus (e.g., RV) Rubella (e.g., MMR, MR, R) Tetanus (e.g., Td) Varicella (e.g., VAR)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Adverse EventTime frame: 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Neuroganics LLC

    Northglenn, Colorado · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.